HHS-NIH-NIAID-BAA2019-1: Research Area 002, Development of Therapeutic Products for Antibiotic Resistant Bacteria

Award Notice Posted

Solicitation number
HHS-NIH-NIAID-BAA2019-1
Agency
Awarded
to Entasis Therapeutics, Inc.
Set-aside
No set-aside

Opportunity facts

Contract number
75N93020C00017 Federal contract award

Notice details come from SAM.gov. Updated .

About this opportunity

Entasis Therapeutics Inc. was awarded a $15,518,919 contract by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to support the development of therapeutic products for antibiotic resistant bacteria under Broad Agency Announcement HHS-NIH-NIAID-BAA2019-1. The contract will fund Entasis Therapeutics' research and development efforts over an unspecified period of performance to produce products aimed at treating antibiotic resistant bacterial infections, in alignment with the National Institute of Allergy and Infectious Diseases' mission to address antimicrobial resistance and the need for novel therapeutics.

Notice text

Awarded contract 75N93020C00017 to ENTASIS THERAPEUTICS INC for 15518919.00 on 2020-06-29.

Notice history

6 of 11 notices listed here. See the rest on GovTribe.

Similar open opportunities

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors